Back

Identification of risk and protective factors in titin cardiomyopathy

21 May 2023 (16:17 - 16:25)
Organised by: Logo
Congress Presentation Part of: From bedside to bench and back Pathophysiology HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Miss Sophie Stroeks

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Proteomic clusters of patients with new onset heart failure; more inflammation and worse prognosis in cluster with preserved ejection fraction - the PREFERS Study
Assistant Professor C. Hage (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Clonal hematopoiesis has prognostic value in dilated cardiomyopathy independent of age and clone size
Mr M. Sikking (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes
Mr F. Deiman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Defect in PKA-mediated proteasome activation is a key pathogenic factor for cardiac proteinopathy
Professor X. Wang (Vermillion, US)
Abstract Slides Video
Presentation thumbnail
ATPase inhibitory factor 1 (ATPIF-1) preserves cardiac function during ageing
Mr P. Sanchez (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
From bedside to bench and back
Video

The Event

Event poster

Heart Failure 2023

21 May 2023 16:17 CET
You may be interested in
thumbnail
Congress Presentation
Exercise intensity and cardiac disease development in carriers of titin variants
thumbnail
Congress Presentation
Exercise intensity and cardiac disease development in carriers of titin variants
thumbnail
Congress Presentation
Targeting titin in dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources